Cargando…

Modeling of Acute Rectal Toxicity to Compare Two Patient Positioning Methods for Prostate Cancer Radiotherapy: Can Toxicity Modeling be Used for Quality Assurance?

PURPOSE: Intensity Modulated Radiation Therapy (IMRT) allows for significant dose reductions to organs at risk in prostate cancer patients. However, the accurate delivery of IMRT plans can be compromised by patient positioning errors. The purpose of this study was to determine if the modeling of gra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, X, Li, J, Schild, SE, Schild, MH, Wong, W, Vora, S, Herman, MG, Fatyga, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376967/ https://www.ncbi.nlm.nih.gov/pubmed/30775161 http://dx.doi.org/10.4172/2167-7964.1000302

Ejemplares similares

Patient Specific Characteristics Are an Important Factor That Determines the Risk of Acute Grade ≥ 2 Rectal Toxicity in Patients Treated for Prostate Cancer with IMRT and Daily Image Guidance Based on Implanted Gold Markers
por: Liu, Xiaonan, et al.
Publicado: (2016)

Statins and Metformin Use Is Associated with Lower PSA Levels in Prostate Cancer Patients Presenting for Radiation Therapy
por: Liu, Xiaonan, et al.
Publicado: (2017)

Nomogram to predict rectal toxicity following prostate cancer radiotherapy
por: Delobel, Jean-Bernard, et al.
Publicado: (2017)

Delivered dose can be a better predictor of rectal toxicity than planned dose in prostate radiotherapy
por: Shelley, L.E.A., et al.
Publicado: (2017)

Predictive modelling for late rectal and urinary toxicities after prostate radiotherapy using planned and delivered dose
por: Ong, Ashley Li Kuan, et al.
Publicado: (2022)

Associations between voxel-level accumulated dose and rectal toxicity in prostate radiotherapy
por: Shelley, Leila E.A., et al.
Publicado: (2020)

Impact of Cardiac Dose on Overall Survival in Lung Stereotactic Body Radiotherapy (SBRT) Compared to Conventionally Fractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
por: Anderson, Justin D., et al.
Publicado: (2021)

Minimal Rectal Toxicity in the Setting of Comorbid Crohn’s Disease Following Prostate Cancer Radiotherapy with a Hydrogel Rectal Spacer
por: Singh, Raj, et al.
Publicado: (2017)

Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma
por: Sanguineti, G, et al.
Publicado: (2002)

Using Novel Statistical Techniques to Accurately Determine the Predictive Dose Range in a Study of Overall Survival after Definitive Radiotherapy for Stage III Non-Small Cell Lung Cancer in Association with Heart Dose
por: Niska, Joshua R., et al.
Publicado: (2021)

Long-term outcomes of prostate intensity-modulated radiation therapy incorporating a simultaneous intra-prostatic MRI-directed boost
por: Laughlin, Brady S., et al.
Publicado: (2022)

Development of a treatment planning protocol for prostate treatments using intensity modulated radiotherapy
por: Ezzell, Gary A., et al.
Publicado: (2001)

Planning With Patient-Specific Rectal Sub-Region Constraints Decreases Probability of Toxicity in Prostate Cancer Radiotherapy
por: Lafond, Caroline, et al.
Publicado: (2020)

Toxicity and outcomes after external beam irradiation for prostate cancer in patients with prior holmium laser enucleation of the prostate: Early experience
por: Laughlin, Brady S., et al.
Publicado: (2022)

Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?
por: Wan, Juefeng, et al.
Publicado: (2015)

Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy: a dose-volume analysis
por: Onal, Cem, et al.
Publicado: (2009)

The evolution of rectal and urinary toxicity and immune response in prostate cancer patients treated with two three-dimensional conformal radiotherapy techniques
por: Vranova, Jana, et al.
Publicado: (2011)

Radiotherapy-induced toxicity in prostate cancer patients with hip prostheses
por: Fischer, Andrea M., et al.
Publicado: (2022)

Positional Reproducibility and Effects of a Rectal Balloon in Prostate Cancer Radiotherapy
por: Cho, Jae Ho, et al.
Publicado: (2009)

Investigating rectal toxicity associated dosimetric features with deformable accumulated rectal surface dose maps for cervical cancer radiotherapy
por: Chen, Jiawei, et al.
Publicado: (2018)

Hematologic Toxicity of Conformal Radiotherapy and Intensity Modulated Radiotherapy in Prostate and Bladder Cancer Patients
por: Miszczyk, Marcin, et al.
Publicado: (2018)

Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer - predictive factors on irritative symptoms, incontinence and rectal bleeding
por: Pinkawa, Michael, et al.
Publicado: (2009)

Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy
por: McDonald, Andrew M, et al.
Publicado: (2014)

Rectal Toxicity After Extremely Hypofractionated Radiotherapy Using a Non-Isocentric Robotic Radiosurgery System for Early Stage Prostate Cancer
por: Shikama, Naoto, et al.
Publicado: (2016)

Machine Learning-Based Models for Prediction of Toxicity Outcomes in Radiotherapy
por: Isaksson, Lars J., et al.
Publicado: (2020)

Rectal endometriosis presenting as toxic megacolon
por: Alvarado, Luis Enrique Rosario, et al.
Publicado: (2021)

Quality assurance devices for dynamic conformal radiotherapy
por: Wong, Victy Y.W.
Publicado: (2004)

Toxicity of dose-escalated radiotherapy up to 84 Gy for prostate cancer
por: Rosenbrock, Johannes, et al.
Publicado: (2023)

Rectal/urinary toxicity after hypofractionated vs conventional radiotherapy in low/intermediate risk localized prostate cancer: systematic review and meta analysis
por: Di Franco, Rossella, et al.
Publicado: (2017)

Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer – results of a randomized phase III trial (RAREST-02)
por: Rades, Dirk, et al.
Publicado: (2022)

Modeling and controller design of periodic discretely controlled continuous systems
por: Schild, Axel
Publicado: (2012)

External validation of pulmonary radiotherapy toxicity models for ultracentral lung tumors
por: Chen, Ishita, et al.
Publicado: (2022)

Effect of Abdominal Circumference on the Irradiated Bowel Volume in Pelvic Radiotherapy for Rectal Cancer Patients: Implications for the Radiotherapy-Related Intestinal Toxicity
por: Wang, Gang, et al.
Publicado: (2022)

Radiotherapy and anthracyclines – cardiovascular toxicity
por: Mozdzanowska, Dagmara, et al.
Publicado: (2014)

Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body Radiotherapy
por: Valle, Luca F., et al.
Publicado: (2020)

Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients
por: Sterzing, Florian, et al.
Publicado: (2015)

Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
por: Cella, Laura, et al.
Publicado: (2013)

Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy
por: Gill, Suki, et al.
Publicado: (2011)

Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
por: D’Avino, Vittoria, et al.
Publicado: (2015)

Effect of patient thickness on acute gastrointestinal toxicities following radiotherapy for prostate cancer
por: Pisani, Robert, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vv1fq5hsskubo3pbs09o5r5bg1